INVASIVE LOBULAR CARCINOMA
Clinical trials for INVASIVE LOBULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INVASIVE LOBULAR CARCINOMA trials appear
Sign up with your email to follow new studies for INVASIVE LOBULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breast cancer trial combines targeted drug with hormone therapy to shrink tumors before surgery
Disease control OngoingThis phase 2 trial investigates whether adding the targeted drug palbociclib to standard endocrine therapy (letrozole or tamoxifen) improves tumor shrinkage before surgery in people with hormone receptor positive, HER2 negative breast cancer. The study includes both invasive lobu…
Matched conditions: INVASIVE LOBULAR CARCINOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Scientists probe Fat-Breast cancer link in 150 patients
Knowledge-focused OngoingThe FATLAS study is looking at how body fat (adiposity) influences breast cancer at both the whole-body and cellular levels. Researchers will enroll 150 breast cancer patients with different body types (lean, overweight, obese) and collect blood, tumor tissue, and body measuremen…
Matched conditions: INVASIVE LOBULAR CARCINOMA
Phase: NA • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC